Abstract
It has been proposed that thyroglobulin (Tg) may be involved in the pathogenesis or the progression of Graves’ ophthalmopathy (GO). According to this hypothesis, following its release from the thyroid, Tg would reach orbital tissues, thereby eliciting an autoimmune aggression. In support of this, we recently found that intact Tg is present in orbital tissues of patients with GO, where it is complexed with glycosaminoglycans. In this study, we searched for additional Tg binding sites in orbital tissues, using primary cultures of orbital and skin fibroblasts from 7 GO patients who had undergone orbital decompression. Biotin-labeled Tg bound to both skin and orbital fibroblasts in a saturable manner, with constants of dissociation of ~75 nmol/l for skin fibroblasts and ~40 nmol/l for orbital fibroblasts. In an attempt to identify Tg binding sites, fibroblast extracts were blotted onto membranes that were incubated with biotin-labeled Tg, which bound especially to a protein migrating at ~300 kDa, present in both orbital and skin fibroblast extracts. Because no appreciable inhibition of binding of biotin-labeled Tg was produced by unlabeled Tg, we concluded that binding was poorly specific and it is unlikely to be involved in the pathogenesis of GO.
Similar content being viewed by others
References
Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves’ disease and ophthalmopathy. Endocr Rev 2003, 24: 802–35.
Bartalena L, Wiersinga WM, Pinchera A. Graves’ ophthalmopathy: state of the art and perspectives. J Endocrinol Invest 2004, 27: 295–301.
Bahn RS. TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves’ ophthalmopathy. J En-docrinol Invest 2004, 27: 216–20.
Many MC, Costagliola S, Detrait M, Denef F, Vassart G, Ludgate MC. Development of an animal model of autoimmune thyroid eye disease. J Immunol 1999, 162: 4966–74.
Marinò M, Chiovato L, Lisi S, Altea MA, Marcocci C, Pinchera A. Role of thyroglobulin in the pathogenesis of Graves’ ophthalmopathy: the hypothesis of Kriss revisited. J Endocrinol Invest 2004, 27: 230–6.
Kriss JP. Radioisotopic thyroidolymphography in patients with Graves’ disease. J Clin Endocrinol Metab 1970, 31: 315–23.
Mullin BR, Levinson RE, Friedman A, Henson DE, Winand RJ, Kohn LD. Delayed hypersensitivity in Graves’ disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle. Endocrinology 1977, 100: 351–66.
Marinò M, Lisi S, Pinchera A, et al. Identification of thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy. Thyroid 2001, 11: 177–85.
Lisi S, Marinò M, Pinchera A, et al. Thyroglobulin in orbital tissues from patients with thyroid associated ophthalmopathy: predominant localization in fibroadipose tissue. Thyroid 2002, 12: 351–60.
Marinò M, Lisi S, Pinchera A, et al. Glycosaminoglycans provide a binding site for thyroglobulin in orbital tissues of patients with thyroid associated ophthalmopathy. Thyroid 2003, 13: 851–9.
Marinò M, Friedlander JA, McCluskey RT, Andrews D. Identification of a heparinbinding region of rat thyroglobulin involved in megalin binding. J Biol Chem 1999, 274: 30377–86.
Spencer CA. Werner and Ingebar’s The thyroid, a fundamental and clinical text. Philadelphia: Lippincott, Williams and Wilkins. 2000, 402.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lisi, S., Botta, R., Agretti, P. et al. Poorly specific binding of thyroglobulin to orbital fibroblasts from patients with Graves’ ophthalmopathy. J Endocrinol Invest 28, 420–424 (2005). https://doi.org/10.1007/BF03347222
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347222